WeVote
Log In

Bill

Bill

SB 1902

MEDICAL LICENSE REVIEW

104th Regular Session Introduced by Suzy Glowiak Hilton

Requires DFPR to review and issue a medical license concurrently with an applicant's controlled-substances registration, speeding access to prescribers.

Rule 3-9(a) / Re-referred to Assignments
0
WeVote Research Nonpartisan
Bill Summary · SB 1902

Summary — SB 1902 (Medical License Review)

Sponsor: Sen. Suzy Glowiak Hilton
Adds Section 9.4 to the Medical Practice Act of 1987 (225 ILCS 60)
Filed: Feb 6, 2025 — Signed by Governor: June 20, 2025 — Effective: upon becoming law

Purpose

SB 1902 requires the Illinois Department of Financial and Professional Regulation (DFPR) to review and issue an applicant’s license to practice medicine concurrently with that applicant’s controlled substances registration application. The intent is to align the timing of physician licensure and controlled-substance prescribing authority to reduce administrative delay between the two authorizations.

Key provisions

  • Amends the Medical Practice Act of 1987 by adding Section 9.4 (225 ILCS 60/9.4).
  • Requires DFPR to review an applicant’s application for a medical license concurrently with the applicant’s application for a controlled substances registration (referencing Section 302 of the Illinois Controlled Substances Act).
  • Requires DFPR to issue the license and the controlled substances registration concurrently.
  • Effective immediately upon the Act becoming law.

Who is affected

  • Applicants for an Illinois license to practice medicine who also apply for controlled substances registration (e.g., physicians seeking authority to prescribe controlled medications).
  • Employers and health care facilities that hire newly licensed physicians and rely on their ability to prescribe controlled substances.
  • DFPR and any agencies or systems that process licensure and controlled-substance registrations (administrative workload, systems integration).
  • Patients who may experience faster access to prescribers authorized to prescribe controlled medications.

Administrative and procedural implications

  • DFPR must coordinate review processes for two separate application types to enable simultaneous review and issuance. This may require procedural changes, staff coordination, or IT/system updates.
  • Because issuance is required to be concurrent, a deficiency or denial in one application (e.g., controlled-substances registration) could affect the timing or issuance of the medical license, and vice versa — potentially altering current adjudicative practices.
  • The statute references controlled substances registration under Section 302 of the Illinois Controlled Substances Act, so inter-agency or inter-division coordination may be necessary.

Legislative status / timeline

  • Introduced Feb 6, 2025. Passed both chambers March–May 2025.
  • Sent to Governor May 27, 2025; signed June 20, 2025.
  • Statutory effective date: upon becoming law (per the bill’s Section 99).

Notes

  • The bill is narrowly focused on synchronizing review and issuance timing; it does not change substantive licensing or controlled-substances eligibility standards.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.